江西沐邦高科股份有限公司 关于公司股票被实施退市风险警示及其他风险警示相关事项的进展公告

Core Viewpoint - The company is facing significant financial challenges, including a negative net profit for 2024 and a risk of delisting due to low revenue and internal control issues [2][3][12]. Group 1: Delisting Risk Warning - The company reported a negative net profit for 2024, and its revenue, after excluding unrelated business income, fell below 300 million yuan, triggering a delisting risk warning effective May 6, 2025 [2][3]. - The company received a negative opinion on its 2024 internal control audit report, which also leads to a risk warning effective May 6, 2025 [4][3]. Group 2: Other Risk Warnings - The company has been flagged for other risks due to non-operational fund occupation by its controlling shareholder and related parties, exceeding 10 million yuan, which was not resolved within one month [4]. - The company announced that the non-operational fund occupation has been cleared as of November 21, 2025 [7]. Group 3: Measures Taken - The company is focusing on controlling liquidity risks, enhancing budget management, and improving operational efficiency while maintaining stability in its core solar product business [5]. - The company is committed to strengthening internal controls and has initiated a comprehensive review and rectification of its internal control systems [7]. - The company has increased compliance training and is enhancing governance execution effectiveness to prevent future non-operational fund occupations [8]. Group 4: Financial Performance - For the first nine months of 2025, the company reported revenue of 226.82 million yuan and a net loss of 355.72 million yuan [12]. - The company faces the risk of being delisted if its 2025 revenue remains below 300 million yuan and if it receives a negative audit opinion [12][13]. Group 5: Legal and Regulatory Issues - The company is currently under investigation by the China Securities Regulatory Commission for alleged financial data misrepresentation [14]. - The actual controller of the company is also under investigation for failing to disclose non-operational fund transactions [14].

banbao-江西沐邦高科股份有限公司 关于公司股票被实施退市风险警示及其他风险警示相关事项的进展公告 - Reportify